ISCO Announces Major Advance in iPS Stem Cell Technology
International Stem Cell Corporation (ISCO:OTCQB), a biotechnology company developing novel stem cell-based ...
ISCO: Third Quarter 2013 Financials and Business Update
International Stem Cell Corp. (ISCO-OTCQB), a biotechnology company developing novel stem cell-based ...
ISCO: New Preclinical Data, Continued Progress for Parkinson's Program
International Stem Cell Corp. (ISCO-OTCQB) has announced new results from its preclinical Parkinson's disease ...
NEW RESEARCH: 12-page Quarterly Update on International Stem Cell
Yesterday, we released a Quarterly Update on International Stem Cell Corporation (ISCO-OTC). This 12-page ...
ISCO Teams Up with Duke for Clinical Research in Parkinson's Disease
Earlier today, International Stem Cell Corporation (ISCO-OTC) announced that it has signed a master clinical ...
NEW RESEARCH: 72-page Report on International Stem Cell Corp. (ISCO)
Yesterday, Crystal Research Associates initiated coverage on International Stem Cell Corporation (ISCO-OTC) ...